Skip to main content

Advertisement

Log in

Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

Advanced glycation end-products (AGEs) are associated with a non-enzymatic reaction between the amino group of a protein and the carbonyl group of a sugar during hyperglycemia. The precipitation of AGEs in different tissues leads to many complications, such as endothelial dysfunction, cardiovascular complications, atherosclerosis, retinopathy, neuropathy, and Alzheimer’s disease. Garcinia mangostana L. (Clusiaceae) (GM) was selected owing to the ability of its polar and non-polar fractions to inhibit AGE formation. For the first time, the bioguided fractionation of its pericarp MeOH extract (GMT) gave rise to two new xanthones, namely, mangostanaxanthones III (1) and IV (3), in addition to six known compounds, β-mangostin (2), garcinone E (4), rubraxanthone (5), α-mangostin (6), garcinone C (7), and 9-hydroxycalabaxanthone (8), from the non-polar faction. Their structures were verified by various spectroscopic methods, including 1D and 2D NMR studies and high-resolution MS data. All of the isolated xanthones significantly inhibited both sugar (ribose) and dicarbonyl compound (methylglyoxal)-induced protein glycation in a dose-dependent manner. This is explained by the ability of the isolated xanthones to inhibit protein oxidation, as indicated by the decreases in dityrosine and N′-formylkynurenine formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18:1–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Seidler NW (2013) Basic biology of GAPDH. Adv Exp Med Biol 985:1–36

    Article  PubMed  Google Scholar 

  3. Lv L, Shao X, Chen H, Ho C-T, Sang S (2011) Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol 24:579–586

    Article  CAS  PubMed  Google Scholar 

  4. Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47:3–27

    Article  CAS  PubMed  Google Scholar 

  5. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ (2005) Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 28:2465–2471

    Article  CAS  PubMed  Google Scholar 

  6. Shanlin FU, Stocker R, Davies MJ (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1–18

    Article  Google Scholar 

  7. Li L, Han A-R, Kinghorn AD, Frye RF, Derendorf H, Butterweck V (2013) Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Planta Med 79:646–653

    Article  CAS  PubMed  Google Scholar 

  8. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML (1993) Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221–232

    Article  CAS  PubMed  Google Scholar 

  9. Sadowska-Bartosz I, Galiniak S, Bartosz G (2014) Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules 19:4880–4896

    Article  CAS  PubMed  Google Scholar 

  10. Okada Y, Okada M (2015) Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells. J Pharm Bioallied Sci 7:145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Devalaraja S, Jain S, Yadav H (2011) Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res Int 44:1856–1865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Abdallah H, El-Bassossy H, El-Halawany A, Mohamed G, Alshali K, Banjar Z (2015) PP. 14.02: Psiadia punctulata and Garcinia mangostana have potent vasorelaxant activity on isolated rat aorta. J Hypertens 33:e246

    Article  Google Scholar 

  13. Abdallah HM, El-Bassossy H, Mohamed GA, El-Halawany AM, Alshali KZ, Banjar ZM (2016) Phenolics from Garcinia mangostana inhibit advanced glycation endproducts formation: effect on Amadori products, cross-linked structures and protein thiols. Molecules 21:251

    Article  PubMed  Google Scholar 

  14. Jia B, Li S, Hu X, Zhu G, Chen W (2015) Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi. AAPS Pharm Sci Tech 16:742–758

    Article  CAS  Google Scholar 

  15. Morel C, Séraphin D, Oger J-M, Litaudon M, Sévenet T, Richomme P, Bruneton J (2000) New xanthones from Calophyllum caledonicum. J Nat Prod 63:1471–1474

    Article  CAS  PubMed  Google Scholar 

  16. Silverstein RM, Webster FX (1998) Spectrometric identification of organic compounds. Wiley, New York

    Google Scholar 

  17. Mohamed GA, Ibrahim SR, Shaaban MI, Ross SA (2014) Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia 98:215–221

    Article  CAS  PubMed  Google Scholar 

  18. Suksamrarn S, Suwannapoch N, Ratananukul P, Aroonlerk N, Suksamrarn A (2002) Xanthones from the Green Fruit Hulls of Garcinia mangostana. J Nat Prod 65:761–763

    Article  CAS  PubMed  Google Scholar 

  19. Iwo MI, Soemardji AA, Hanafi M (2013) Sunscreen activity of [alpha]-mangostin from the pericarps of Garcinia mangostana. J Appl Pharm Sci 3:70

    Google Scholar 

  20. Ha LD, Hansen PE, Vang O, Duus F, Pham HD, Nguyen L-HD (2009) Cytotoxic geranylated xanthones and O-alkylated derivatives of alpha.-mangostin. Chem Pharm Bull 57:830–834

    Article  CAS  PubMed  Google Scholar 

  21. Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvuori R, Hase TA (1982) The structures of garcinones A, B and C: three new xanthones from Garcinia mangostana. Phytochemistry 21:1747–1750

    Article  CAS  Google Scholar 

  22. Ampofo SA, Waterman PG (1986) Xanthones from three Garcinia species. Phytochemistry 25:2351–2355

    Article  CAS  Google Scholar 

  23. Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvuori R, Haset TA (1980) A xanthone from Garcinia mangostana. Phytochemistry 19:2223–2225

    Article  CAS  Google Scholar 

  24. Wu C-H, Huang S-M, Lin J-A, Yen G-C (2011) Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct 2:224–234

    Article  CAS  PubMed  Google Scholar 

  25. Bechtold U, Rabbani N, Mullineaux PM, Thornalley PJ (2009) Quantitative measurement of specific biomarkers for protein oxidation, nitration and glycation in Arabidopsis leaves. Plant J 59:661–671

    Article  CAS  PubMed  Google Scholar 

  26. Mahabusarakam W, Proudfoot J, Taylor W, Croft K (2000) Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic Res 33:643–659

    Article  CAS  PubMed  Google Scholar 

  27. Thong NM, Quang DT, Bui NHT, Dao DQ, Nam PC (2015) Antioxidant properties of xanthones extracted from the pericarp of Garcinia mangostana (Mangosteen): a theoretical study. Chem Phys Lett 625:30–35

    Article  Google Scholar 

  28. Jariyapongskul A, Areebambud C, Suksamrarn S, Mekseepralard C (2015) Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed Res Int 2015:785826

    Article  PubMed  PubMed Central  Google Scholar 

  29. Minami H, Kinoshita M, Fukuyama Y, Kodama M, Yoshizawa T, Sugiura M, Nakagawa K, Tago H (1994) Antioxidant xanthones from Garcinia subelliptica. Phytochemistry 36:501–506

    Article  CAS  Google Scholar 

  30. Cahyana AH, Wibowo W, Abdullah I (2015) Prenylation of xanthone extract from Mangosteen (Garcinia mangostana L.) rind by using superbase catalyst of [gamma]-alumina/NaOH/Na and antioxidant activity test. Asian J Chem 27:2228

    Article  CAS  Google Scholar 

  31. Ferchichi L, Derbré S, Mahmood K, Touré K, Guilet D, Litaudon M, Awang K, Hadi AHA, Le Ray AM, Richomme P (2012) Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. Phytochemistry 78:98–106

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, the Kingdom of Saudi Arabia, Award Number 12-BIO3087-03. The authors also acknowledge with thanks the Science and Technology Unit, King Abdulaziz University, for the technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hossam M. Abdallah.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdallah, H.M., El-Bassossy, H.M., Mohamed, G.A. et al. Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana . J Nat Med 71, 216–226 (2017). https://doi.org/10.1007/s11418-016-1051-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-016-1051-8

Keywords

Navigation